Immunoassay Market by Type, Technology, Instruments, Sample Types, Detection Modes, Application Areas, End Users, Deployment Types

The Immunoassay Market is projected to reach USD 32.61 Billion in 2026. It is expected to continue growing at a CAGR of 7.36%, reaching USD 49.98 Billion by 2032.

Immunoassay is a core analytical technology in modern diagnostics, using highly specific antigen-antibody binding to detect biomarkers in blood, serum, plasma, saliva, urine, and other specimen types. Established formats such as enzyme-linked immunosorbent assay (ELISA), chemiluminescent immunoassay, fluorescence immunoassay, radioimmunoassay, and lateral flow immunoassay support clinical testing across infectious disease, oncology, cardiology, endocrinology, allergy, toxicology, autoimmune disease, fertility, and therapeutic drug monitoring.

Demand is supported by measurable healthcare needs, including aging populations, chronic disease prevalence, antimicrobial resistance surveillance, prenatal screening, blood safety, and pandemic preparedness. The World Health Organization reports that noncommunicable diseases account for about 74% of global deaths, reinforcing the need for scalable biomarker testing. Immunoassay remains strategically important because it combines scalable throughput, clinical familiarity, automation compatibility, cost-efficient workflows, and rapid turnaround for centralized laboratories and decentralized point-of-care testing.

Transformative Shifts in the Immunoassay Landscape

The immunoassay landscape is shifting from standalone, manual workflows toward automated, connected, and multiplexed diagnostic ecosystems. Clinical laboratories are prioritizing high-throughput analyzers, standardized reagent platforms, quality controls, and interfaces with laboratory information systems to reduce variability, improve traceability, and support faster clinical decisions.

At the same time, point-of-care immunoassay adoption is expanding as health systems seek earlier detection outside central labs, especially in emergency departments, primary care, pharmacies, rural clinics, and outbreak settings. Regulatory scrutiny is also increasing, particularly under the EU In Vitro Diagnostic Regulation and FDA oversight of higher-risk diagnostics, making analytical validation, clinical performance evidence, risk management, usability, and post-market surveillance essential competitive differentiators.

Cumulative Impact of Artificial Intelligence on Immunoassay

Artificial intelligence is becoming an operational accelerator for immunoassay development and deployment. AI-enabled image analysis can improve interpretation of lateral flow and fluorescence results, while machine learning supports assay optimization by modeling antibody-antigen interactions, background noise, cross-reactivity risk, interference patterns, and calibration curve performance.

In laboratories, AI contributes to predictive maintenance, workload forecasting, reflex-testing rules, result verification, and anomaly detection in quality control data. Its strongest near-term value is not replacing immunoassay science but improving reproducibility, throughput, and clinical integration when paired with validated datasets, transparent governance, cybersecurity controls, human oversight, and regulatory-grade documentation.

Key Regional Insights for Immunoassay

Asia-Pacific is a dynamic immunoassay region because China, India, Japan, South Korea, Australia, and Southeast Asian economies combine large patient pools with expanding diagnostic infrastructure, rising chronic disease testing, and greater use of automated and point-of-care platforms. North America remains highly mature, supported by regulated innovation, hospital networks, reference laboratories, reimbursement pathways, public health testing capacity, and strong uptake of automated immunoassay platforms for infectious disease, endocrine, cardiac, oncology, and therapeutic monitoring applications.

Europe is shaped by advanced laboratory medicine, national screening programs, accreditation practices, and stricter In Vitro Diagnostic Regulation evidence requirements, which increase the importance of clinical validation and post-market performance monitoring. Latin America is improving immunoassay access through private laboratory chains, public screening initiatives, and infectious disease testing for conditions such as dengue, HIV, hepatitis, and respiratory infections. The Middle East is investing in hospital modernization, preventive screening, specialty diagnostics, and laboratory automation, while Africa’s opportunity is strongly linked to scalable point-of-care immunoassays for HIV, malaria, hepatitis, pregnancy, tuberculosis screening support, and outbreak response, where decentralized testing can close access gaps in underserved areas.

Key Group Insights for Immunoassay

ASEAN countries are expanding immunoassay use through infectious disease surveillance, maternal health programs, hospital laboratory upgrades, and rising private diagnostics demand across urban centers. The GCC is investing in high-acuity hospitals, laboratory automation, local health security capacity, and preventive screening aligned with national health transformation agendas. The European Union is increasingly evidence-driven under IVDR, favoring suppliers with robust clinical validation, traceability, quality management systems, and documented post-market surveillance.

BRICS markets offer scale and localization potential, particularly where public procurement, domestic manufacturing policies, technology transfer, and access-oriented pricing influence adoption. G7 markets lead in premium analyzer adoption, companion diagnostics, reimbursement standards, laboratory accreditation, and digital laboratory integration. NATO members’ broader emphasis on health security also supports immunoassay capacity for biodefense readiness, blood safety, outbreak preparedness, military medical services, and deployable diagnostics in emergency settings.

Key Country Insights for Immunoassay

The United States leads immunoassay commercialization through large reference laboratories, integrated hospital systems, established FDA pathways, and strong demand for oncology, cardiac, infectious disease, autoimmune, allergy, and endocrine testing. Canada emphasizes quality-assured diagnostics within publicly funded care, while Mexico and Brazil combine infectious disease testing needs, chronic disease screening, and expanding private laboratory networks. The United Kingdom, Germany, France, Italy, and Spain remain central to European immunoassay adoption, supported by established clinical guidelines, laboratory accreditation, universal or near-universal healthcare systems, and advanced infrastructure.

Russia maintains demand for essential diagnostics despite procurement complexity and supply chain constraints. China and India are major growth engines due to population scale, chronic disease burden, domestic manufacturing capacity, expanding hospital networks, and public health testing needs. Japan, Australia, and South Korea are advanced immunoassay markets where automation, high-quality reagents, aging demographics, precision diagnostics, and strong laboratory quality standards continue to drive adoption across centralized and decentralized testing environments.

Actionable Recommendations for Immunoassay Industry Leaders

Industry leaders should prioritize assay menus with clear clinical utility, including infectious disease, cardiac markers, thyroid function, fertility, oncology biomarkers, autoimmune testing, allergy diagnostics, inflammation markers, and therapeutic drug monitoring. Competitive advantage will come from proven sensitivity, specificity, reproducibility, lot-to-lot consistency, calibration stability, interference management, and seamless analyzer integration.

Organizations should also invest in regional regulatory readiness, IVDR transition planning, quality system maturity, cybersecurity for connected analyzers, and AI governance. Partnerships with hospitals, reference laboratories, public health agencies, academic centers, and local distributors can improve evidence generation, reimbursement access, user training, service uptime, and adoption in both mature and emerging immunoassay markets.

Research Methodology

This executive summary is based on a structured review of publicly available, authoritative sources, including regulatory agency guidance, clinical laboratory standards, World Health Organization resources, peer-reviewed literature, health system reports, public procurement information, and disclosures from established diagnostics manufacturers.

The analysis evaluates immunoassay technologies, clinical applications, regional healthcare drivers, country-level diagnostic infrastructure, regulatory conditions, laboratory automation trends, point-of-care testing adoption, and AI-enabled workflow integration. Insights were synthesized using evidence triangulation, prioritizing verifiable facts over unsupported claims and excluding speculative data that could not be linked to credible healthcare, diagnostics, regulatory, or laboratory medicine indicators.

Conclusion

Immunoassay will remain a foundational diagnostics category because it addresses high-volume clinical needs while adapting to automation, multiplexing, point-of-care testing, digital connectivity, and AI-enabled workflow support. The category’s long-term relevance is reinforced by chronic disease management, infectious disease surveillance, preventive screening, blood safety, therapeutic monitoring, and precision medicine.

The next phase of leadership will depend on validated performance, regulatory discipline, accessible pricing, resilient supply chains, and intelligent workflow integration. Organizations that combine scientific reliability with scalable manufacturing, strong quality systems, clinical evidence, and evidence-based commercialization will be best positioned to meet demand across global immunoassay markets.

Additional Product Information:

Purchase of this report includes 1 year online access with quarterly updates.
This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

1. Preface

1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders

2. Research Methodology

2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations

3. Executive Summary

3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap

4. Market Overview

4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy

5. Market Insights

5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Immunoassay Market, by Type

7.1. Qualitative Immunoassays
7.2. Quantitative Immunoassays

8. Immunoassay Market, by Technology

8.1. Enzyme Immunoassays
8.2. Enzyme-Linked Immunosorbent Assay
8.3. Fluorescent Immunoassay
8.4. Lateral Flow Assay
8.5. Radioimmunoassay
8.6. Western Blot

9. Immunoassay Market, by Instruments

9.1. Analyzers & Kits
9.2. Biosensors
9.3. Microfluidic Devices
9.4. Microplates
9.5. PCR Devices
9.6. Reagents
9.6.1. Antibodies
9.6.2. Antigens
9.6.3. Blocking Reagents
9.6.4. Buffers & Standards
9.6.5. Enzymes
9.6.6. Substrates
9.7. Software & Services

10. Immunoassay Market, by Sample Types

10.1. Blood Samples
10.2. Saliva Samples
10.3. Tissue Samples
10.4. Urine Samples

11. Immunoassay Market, by Detection Modes

11.1. Chemiluminescent
11.2. Colorimetric
11.3. Fluorometric
11.4. Radioisotopic

12. Immunoassay Market, by Application Areas

12.1. Allergy
12.2. Autoimmune Diseases
12.3. Cardiology
12.4. Endocrinology
12.5. Infectious Diseases
12.6. Oncology
12.7. Toxicology
12.7.1. Drug Screening
12.7.2. Environmental Testing

13. Immunoassay Market, by End Users

13.1. Contract Research Organizations
13.2. Diagnostic Laboratories
13.3. Hospitals & Clinics
13.4. Pharmaceutical & Biotechnology Companies
13.5. Research Institutions

14. Immunoassay Market, by Deployment Types

14.1. Laboratory Tests
14.2. Point-of-care Test

15. Asia-Pacific Immunoassay Market
16. North America Immunoassay Market
17. Latin America Immunoassay Market
18. Europe Immunoassay Market
19. Middle East Immunoassay Market
20. Africa Immunoassay Market
21. ASEAN Immunoassay Market
22. GCC Immunoassay Market
23. European Union Immunoassay Market
24. BRICS Immunoassay Market
25. G7 Immunoassay Market
26. NATO Immunoassay Market
27. United States Immunoassay Market
28. Germany Immunoassay Market
29. China Immunoassay Market
30. United Kingdom Immunoassay Market
31. India Immunoassay Market
32. Japan Immunoassay Market
33. Russia Immunoassay Market
34. Brazil Immunoassay Market
35. Canada Immunoassay Market
36. Italy Immunoassay Market
37. Mexico Immunoassay Market
38. France Immunoassay Market
39. Spain Immunoassay Market
40. Australia Immunoassay Market
41. South Korea Immunoassay Market

42. Competitive Landscape

42.1. Market Concentration Analysis, 2025
42.1.1. Concentration Ratio (CR)
42.1.2. Herfindahl Hirschman Index (HHI)
42.2. Recent Developments & Impact Analysis, 2025
42.3. Product Portfolio Analysis, 2025
42.4. Benchmarking Analysis, 2025

43. Company Profiles

43.1. Abbott Laboratories
43.2. Agilent Technologies Inc.
43.3. ANP Technologies, Inc.
43.4. Autobio Diagnostics Co., Ltd.
43.5. Becton, Dickinson and Company
43.6. Bio-Rad Laboratories, Inc.
43.7. Bio-Techne Corporation
43.8. bioMérieux S.A.
43.9. Biosurfit SA
43.10. Boditech Med Inc.
43.11. Danaher Corporation
43.12. Diasorin S.p.A.
43.13. Dynex Technologies, Inc.
43.14. Epitope Diagnostics Inc.
43.15. F. Hoffmann-La Roche Ltd.
43.16. Fapon Biotech Inc.
43.17. H.U. Group Holdings Inc.
43.18. J. Mitra & Co. Pvt. Ltd.
43.19. Kamiya Biomedical Company
43.20. Merck KGaA
43.21. MiCo BioMed, Inc.
43.22. NanoEntek
43.23. Nanomix, Inc.
43.24. OPKO Health, Inc.
43.25. Promega Corporation
43.26. QIAGEN N.V.
43.27. Quanterix Corporation
43.28. Randox Laboratories Ltd.
43.29. Shenzhen Micropoint Biotechnologies Co., Ltd.
43.30. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
43.31. Siemens Healthineers AG
43.32. Sysmex Corporation
43.33. Thermo Fisher Scientific Inc.
43.34. Tosoh Corporation
43.35. WAK-Chemie Medical GmbH
43.36. Zoetis Inc.
43.37. Zybio Inc.

List of Figures

FIGURE 1. GLOBAL IMMUNOASSAY MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL IMMUNOASSAY MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL IMMUNOASSAY MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL IMMUNOASSAY MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL IMMUNOASSAY MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 6. GLOBAL IMMUNOASSAY MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 7. GLOBAL IMMUNOASSAY MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL IMMUNOASSAY MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 9. GLOBAL IMMUNOASSAY MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL IMMUNOASSAY MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 11. GLOBAL IMMUNOASSAY MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL IMMUNOASSAY MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 13. GLOBAL IMMUNOASSAY MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
FIGURE 14. GLOBAL IMMUNOASSAY MARKET SIZE, BY TYPE, 2025 VS 2032 (%)
FIGURE 15. GLOBAL IMMUNOASSAY MARKET SIZE, BY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2025 VS 2032 (%)
FIGURE 17. GLOBAL IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL IMMUNOASSAY MARKET SIZE, BY INSTRUMENTS, 2025 VS 2032 (%)
FIGURE 19. GLOBAL IMMUNOASSAY MARKET SIZE, BY INSTRUMENTS, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL IMMUNOASSAY MARKET SIZE, BY SAMPLE TYPES, 2025 VS 2032 (%)
FIGURE 21. GLOBAL IMMUNOASSAY MARKET SIZE, BY SAMPLE TYPES, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL IMMUNOASSAY MARKET SIZE, BY DETECTION MODES, 2025 VS 2032 (%)
FIGURE 23. GLOBAL IMMUNOASSAY MARKET SIZE, BY DETECTION MODES, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 24. GLOBAL IMMUNOASSAY MARKET SIZE, BY APPLICATION AREAS, 2025 VS 2032 (%)
FIGURE 25. GLOBAL IMMUNOASSAY MARKET SIZE, BY APPLICATION AREAS, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 26. GLOBAL IMMUNOASSAY MARKET SIZE, BY END USERS, 2025 VS 2032 (%)
FIGURE 27. GLOBAL IMMUNOASSAY MARKET SIZE, BY END USERS, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 28. GLOBAL IMMUNOASSAY MARKET SIZE, BY DEPLOYMENT TYPES, 2025 VS 2032 (%)
FIGURE 29. GLOBAL IMMUNOASSAY MARKET SIZE, BY DEPLOYMENT TYPES, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 30. ASIA-PACIFIC IMMUNOASSAY MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 31. ASIA-PACIFIC IMMUNOASSAY MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 32. NORTH AMERICA IMMUNOASSAY MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 33. NORTH AMERICA IMMUNOASSAY MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 34. LATIN AMERICA IMMUNOASSAY MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 35. LATIN AMERICA IMMUNOASSAY MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 36. EUROPE IMMUNOASSAY MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 37. EUROPE IMMUNOASSAY MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 38. MIDDLE EAST IMMUNOASSAY MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 39. MIDDLE EAST IMMUNOASSAY MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 40. AFRICA IMMUNOASSAY MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 41. AFRICA IMMUNOASSAY MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 42. ASEAN IMMUNOASSAY MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 43. ASEAN IMMUNOASSAY MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 44. GCC IMMUNOASSAY MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 45. GCC IMMUNOASSAY MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 46. EUROPEAN UNION IMMUNOASSAY MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 47. EUROPEAN UNION IMMUNOASSAY MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 48. BRICS IMMUNOASSAY MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 49. BRICS IMMUNOASSAY MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 50. G7 IMMUNOASSAY MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 51. G7 IMMUNOASSAY MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 52. NATO IMMUNOASSAY MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 53. NATO IMMUNOASSAY MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 54. UNITED STATES IMMUNOASSAY MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 55. GERMANY IMMUNOASSAY MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 56. CHINA IMMUNOASSAY MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 57. UNITED KINGDOM IMMUNOASSAY MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 58. INDIA IMMUNOASSAY MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 59. JAPAN IMMUNOASSAY MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 60. RUSSIA IMMUNOASSAY MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 61. BRAZIL IMMUNOASSAY MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 62. CANADA IMMUNOASSAY MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 63. ITALY IMMUNOASSAY MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 64. MEXICO IMMUNOASSAY MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 65. FRANCE IMMUNOASSAY MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 66. SPAIN IMMUNOASSAY MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 67. AUSTRALIA IMMUNOASSAY MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 68. SOUTH KOREA IMMUNOASSAY MARKET SIZE, 2018-2032 (USD MILLION)

List of Tables

TABLE 1. GLOBAL IMMUNOASSAY MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL IMMUNOASSAY MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL IMMUNOASSAY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL IMMUNOASSAY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL IMMUNOASSAY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL IMMUNOASSAY MARKET SHARE, BY KEY PLAYER, 2025
TABLE 7. GLOBAL IMMUNOASSAY MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
TABLE 8. GLOBAL IMMUNOASSAY MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL QUALITATIVE IMMUNOASSAYS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL QUALITATIVE IMMUNOASSAYS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL QUALITATIVE IMMUNOASSAYS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL QUANTITATIVE IMMUNOASSAYS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL QUANTITATIVE IMMUNOASSAYS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL QUANTITATIVE IMMUNOASSAYS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL ENZYME IMMUNOASSAYS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL ENZYME IMMUNOASSAYS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL ENZYME IMMUNOASSAYS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL FLUORESCENT IMMUNOASSAY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL FLUORESCENT IMMUNOASSAY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL FLUORESCENT IMMUNOASSAY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL LATERAL FLOW ASSAY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL LATERAL FLOW ASSAY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL LATERAL FLOW ASSAY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL RADIOIMMUNOASSAY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL RADIOIMMUNOASSAY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL RADIOIMMUNOASSAY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL WESTERN BLOT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL WESTERN BLOT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL WESTERN BLOT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL IMMUNOASSAY MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL ANALYZERS & KITS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL ANALYZERS & KITS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL ANALYZERS & KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL BIOSENSORS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL BIOSENSORS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL BIOSENSORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL MICROFLUIDIC DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL MICROFLUIDIC DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL MICROFLUIDIC DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL MICROPLATES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL MICROPLATES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL MICROPLATES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL PCR DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL PCR DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL PCR DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL REAGENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL REAGENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL REAGENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL ANTIBODIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL ANTIBODIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL ANTIBODIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL ANTIGENS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL ANTIGENS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL ANTIGENS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL BLOCKING REAGENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL BLOCKING REAGENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL BLOCKING REAGENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL BUFFERS & STANDARDS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL BUFFERS & STANDARDS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL BUFFERS & STANDARDS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL ENZYMES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL ENZYMES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL ENZYMES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL SUBSTRATES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL SUBSTRATES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL SUBSTRATES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL SOFTWARE & SERVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL SOFTWARE & SERVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL SOFTWARE & SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL IMMUNOASSAY MARKET SIZE, BY SAMPLE TYPES, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL BLOOD SAMPLES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL BLOOD SAMPLES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL BLOOD SAMPLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL SALIVA SAMPLES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL SALIVA SAMPLES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL SALIVA SAMPLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL TISSUE SAMPLES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL TISSUE SAMPLES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL TISSUE SAMPLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL URINE SAMPLES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL URINE SAMPLES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL URINE SAMPLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL IMMUNOASSAY MARKET SIZE, BY DETECTION MODES, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL CHEMILUMINESCENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL CHEMILUMINESCENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL CHEMILUMINESCENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL COLORIMETRIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL COLORIMETRIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL COLORIMETRIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL FLUOROMETRIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL FLUOROMETRIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL FLUOROMETRIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL RADIOISOTOPIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL RADIOISOTOPIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL RADIOISOTOPIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL IMMUNOASSAY MARKET SIZE, BY APPLICATION AREAS, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL ALLERGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL ALLERGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL ALLERGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 104. GLOBAL AUTOIMMUNE DISEASES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 105. GLOBAL AUTOIMMUNE DISEASES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 106. GLOBAL AUTOIMMUNE DISEASES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 107. GLOBAL CARDIOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 108. GLOBAL CARDIOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 109. GLOBAL CARDIOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 110. GLOBAL ENDOCRINOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 111. GLOBAL ENDOCRINOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 112. GLOBAL ENDOCRINOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 113. GLOBAL INFECTIOUS DISEASES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 114. GLOBAL INFECTIOUS DISEASES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 115. GLOBAL INFECTIOUS DISEASES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 116. GLOBAL ONCOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 117. GLOBAL ONCOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 118. GLOBAL ONCOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 119. GLOBAL TOXICOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 120. GLOBAL TOXICOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 121. GLOBAL TOXICOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 122. GLOBAL DRUG SCREENING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 123. GLOBAL DRUG SCREENING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 124. GLOBAL DRUG SCREENING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 125. GLOBAL ENVIRONMENTAL TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 126. GLOBAL ENVIRONMENTAL TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 127. GLOBAL ENVIRONMENTAL TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 128. GLOBAL IMMUNOASSAY MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
TABLE 129. GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 130. GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 131. GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 132. GLOBAL DIAGNOSTIC LABORATORIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 133. GLOBAL DIAGNOSTIC LABORATORIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 134. GLOBAL DIAGNOSTIC LABORATORIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 135. GLOBAL HOSPITALS & CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 136. GLOBAL HOSPITALS & CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 137. GLOBAL HOSPITALS & CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 138. GLOBAL PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 139. GLOBAL PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 140. GLOBAL PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 141. GLOBAL RESEARCH INSTITUTIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 142. GLOBAL RESEARCH INSTITUTIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 143. GLOBAL RESEARCH INSTITUTIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 144. GLOBAL IMMUNOASSAY MARKET SIZE, BY DEPLOYMENT TYPES, 2018-2032 (USD MILLION)
TABLE 145. GLOBAL LABORATORY TESTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 146. GLOBAL LABORATORY TESTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 147. GLOBAL LABORATORY TESTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 148. GLOBAL POINT-OF-CARE TEST MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 149. GLOBAL POINT-OF-CARE TEST MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 150. GLOBAL POINT-OF-CARE TEST MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 151. ASIA-PACIFIC IMMUNOASSAY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 152. ASIA-PACIFIC IMMUNOASSAY MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 153. ASIA-PACIFIC IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 154. ASIA-PACIFIC IMMUNOASSAY MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 155. ASIA-PACIFIC IMMUNOASSAY MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 156. ASIA-PACIFIC IMMUNOASSAY MARKET SIZE, BY SAMPLE TYPES, 2018-2032 (USD MILLION)
TABLE 157. ASIA-PACIFIC IMMUNOASSAY MARKET SIZE, BY DETECTION MODES, 2018-2032 (USD MILLION)
TABLE 158. ASIA-PACIFIC IMMUNOASSAY MARKET SIZE, BY APPLICATION AREAS, 2018-2032 (USD MILLION)
TABLE 159. ASIA-PACIFIC IMMUNOASSAY MARKET SIZE, BY TOXICOLOGY, 2018-2032 (USD MILLION)
TABLE 160. ASIA-PACIFIC IMMUNOASSAY MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
TABLE 161. ASIA-PACIFIC IMMUNOASSAY MARKET SIZE, BY DEPLOYMENT TYPES, 2018-2032 (USD MILLION)
TABLE 162. NORTH AMERICA IMMUNOASSAY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 163. NORTH AMERICA IMMUNOASSAY MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 164. NORTH AMERICA IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 165. NORTH AMERICA IMMUNOASSAY MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 166. NORTH AMERICA IMMUNOASSAY MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 167. NORTH AMERICA IMMUNOASSAY MARKET SIZE, BY SAMPLE TYPES, 2018-2032 (USD MILLION)
TABLE 168. NORTH AMERICA IMMUNOASSAY MARKET SIZE, BY DETECTION MODES, 2018-2032 (USD MILLION)
TABLE 169. NORTH AMERICA IMMUNOASSAY MARKET SIZE, BY APPLICATION AREAS, 2018-2032 (USD MILLION)
TABLE 170. NORTH AMERICA IMMUNOASSAY MARKET SIZE, BY TOXICOLOGY, 2018-2032 (USD MILLION)
TABLE 171. NORTH AMERICA IMMUNOASSAY MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
TABLE 172. NORTH AMERICA IMMUNOASSAY MARKET SIZE, BY DEPLOYMENT TYPES, 2018-2032 (USD MILLION)
TABLE 173. LATIN AMERICA IMMUNOASSAY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 174. LATIN AMERICA IMMUNOASSAY MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 175. LATIN AMERICA IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 176. LATIN AMERICA IMMUNOASSAY MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 177. LATIN AMERICA IMMUNOASSAY MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 178. LATIN AMERICA IMMUNOASSAY MARKET SIZE, BY SAMPLE TYPES, 2018-2032 (USD MILLION)
TABLE 179. LATIN AMERICA IMMUNOASSAY MARKET SIZE, BY DETECTION MODES, 2018-2032 (USD MILLION)
TABLE 180. LATIN AMERICA IMMUNOASSAY MARKET SIZE, BY APPLICATION AREAS, 2018-2032 (USD MILLION)
TABLE 181. LATIN AMERICA IMMUNOASSAY MARKET SIZE, BY TOXICOLOGY, 2018-2032 (USD MILLION)
TABLE 182. LATIN AMERICA IMMUNOASSAY MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
TABLE 183. LATIN AMERICA IMMUNOASSAY MARKET SIZE, BY DEPLOYMENT TYPES, 2018-2032 (USD MILLION)
TABLE 184. EUROPE IMMUNOASSAY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 185. EUROPE IMMUNOASSAY MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 186. EUROPE IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 187. EUROPE IMMUNOASSAY MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 188. EUROPE IMMUNOASSAY MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 189. EUROPE IMMUNOASSAY MARKET SIZE, BY SAMPLE TYPES, 2018-2032 (USD MILLION)
TABLE 190. EUROPE IMMUNOASSAY MARKET SIZE, BY DETECTION MODES, 2018-2032 (USD MILLION)
TABLE 191. EUROPE IMMUNOASSAY MARKET SIZE, BY APPLICATION AREAS, 2018-2032 (USD MILLION)
TABLE 192. EUROPE IMMUNOASSAY MARKET SIZE, BY TOXICOLOGY, 2018-2032 (USD MILLION)
TABLE 193. EUROPE IMMUNOASSAY MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
TABLE 194. EUROPE IMMUNOASSAY MARKET SIZE, BY DEPLOYMENT TYPES, 2018-2032 (USD MILLION)
TABLE 195. MIDDLE EAST IMMUNOASSAY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 196. MIDDLE EAST IMMUNOASSAY MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 197. MIDDLE EAST IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 198. MIDDLE EAST IMMUNOASSAY MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 199. MIDDLE EAST IMMUNOASSAY MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 200. MIDDLE EAST IMMUNOASSAY MARKET SIZE, BY SAMPLE TYPES, 2018-2032 (USD MILLION)
TABLE 201. MIDDLE EAST IMMUNOASSAY MARKET SIZE, BY DETECTION MODES, 2018-2032 (USD MILLION)
TABLE 202. MIDDLE EAST IMMUNOASSAY MARKET SIZE, BY APPLICATION AREAS, 2018-2032 (USD MILLION)
TABLE 203. MIDDLE EAST IMMUNOASSAY MARKET SIZE, BY TOXICOLOGY, 2018-2032 (USD MILLION)
TABLE 204. MIDDLE EAST IMMUNOASSAY MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
TABLE 205. MIDDLE EAST IMMUNOASSAY MARKET SIZE, BY DEPLOYMENT TYPES, 2018-2032 (USD MILLION)
TABLE 206. AFRICA IMMUNOASSAY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 207. AFRICA IMMUNOASSAY MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 208. AFRICA IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 209. AFRICA IMMUNOASSAY MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 210. AFRICA IMMUNOASSAY MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 211. AFRICA IMMUNOASSAY MARKET SIZE, BY SAMPLE TYPES, 2018-2032 (USD MILLION)
TABLE 212. AFRICA IMMUNOASSAY MARKET SIZE, BY DETECTION MODES, 2018-2032 (USD MILLION)
TABLE 213. AFRICA IMMUNOASSAY MARKET SIZE, BY APPLICATION AREAS, 2018-2032 (USD MILLION)
TABLE 214. AFRICA IMMUNOASSAY MARKET SIZE, BY TOXICOLOGY, 2018-2032 (USD MILLION)
TABLE 215. AFRICA IMMUNOASSAY MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
TABLE 216. AFRICA IMMUNOASSAY MARKET SIZE, BY DEPLOYMENT TYPES, 2018-2032 (USD MILLION)
TABLE 217. ASEAN IMMUNOASSAY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 218. ASEAN IMMUNOASSAY MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 219. ASEAN IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 220. ASEAN IMMUNOASSAY MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 221. ASEAN IMMUNOASSAY MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 222. ASEAN IMMUNOASSAY MARKET SIZE, BY SAMPLE TYPES, 2018-2032 (USD MILLION)
TABLE 223. ASEAN IMMUNOASSAY MARKET SIZE, BY DETECTION MODES, 2018-2032 (USD MILLION)
TABLE 224. ASEAN IMMUNOASSAY MARKET SIZE, BY APPLICATION AREAS, 2018-2032 (USD MILLION)
TABLE 225. ASEAN IMMUNOASSAY MARKET SIZE, BY TOXICOLOGY, 2018-2032 (USD MILLION)
TABLE 226. ASEAN IMMUNOASSAY MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
TABLE 227. ASEAN IMMUNOASSAY MARKET SIZE, BY DEPLOYMENT TYPES, 2018-2032 (USD MILLION)
TABLE 228. GCC IMMUNOASSAY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 229. GCC IMMUNOASSAY MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 230. GCC IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 231. GCC IMMUNOASSAY MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 232. GCC IMMUNOASSAY MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 233. GCC IMMUNOASSAY MARKET SIZE, BY SAMPLE TYPES, 2018-2032 (USD MILLION)
TABLE 234. GCC IMMUNOASSAY MARKET SIZE, BY DETECTION MODES, 2018-2032 (USD MILLION)
TABLE 235. GCC IMMUNOASSAY MARKET SIZE, BY APPLICATION AREAS, 2018-2032 (USD MILLION)
TABLE 236. GCC IMMUNOASSAY MARKET SIZE, BY TOXICOLOGY, 2018-2032 (USD MILLION)
TABLE 237. GCC IMMUNOASSAY MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
TABLE 238. GCC IMMUNOASSAY MARKET SIZE, BY DEPLOYMENT TYPES, 2018-2032 (USD MILLION)
TABLE 239. EUROPEAN UNION IMMUNOASSAY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 240. EUROPEAN UNION IMMUNOASSAY MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 241. EUROPEAN UNION IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 242. EUROPEAN UNION IMMUNOASSAY MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 243. EUROPEAN UNION IMMUNOASSAY MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 244. EUROPEAN UNION IMMUNOASSAY MARKET SIZE, BY SAMPLE TYPES, 2018-2032 (USD MILLION)
TABLE 245. EUROPEAN UNION IMMUNOASSAY MARKET SIZE, BY DETECTION MODES, 2018-2032 (USD MILLION)
TABLE 246. EUROPEAN UNION IMMUNOASSAY MARKET SIZE, BY APPLICATION AREAS, 2018-2032 (USD MILLION)
TABLE 247. EUROPEAN UNION IMMUNOASSAY MARKET SIZE, BY TOXICOLOGY, 2018-2032 (USD MILLION)
TABLE 248. EUROPEAN UNION IMMUNOASSAY MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
TABLE 249. EUROPEAN UNION IMMUNOASSAY MARKET SIZE, BY DEPLOYMENT TYPES, 2018-2032 (USD MILLION)
TABLE 250. BRICS IMMUNOASSAY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 251. BRICS IMMUNOASSAY MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 252. BRICS IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 253. BRICS IMMUNOASSAY MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 254. BRICS IMMUNOASSAY MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 255. BRICS IMMUNOASSAY MARKET SIZE, BY SAMPLE TYPES, 2018-2032 (USD MILLION)
TABLE 256. BRICS IMMUNOASSAY MARKET SIZE, BY DETECTION MODES, 2018-2032 (USD MILLION)
TABLE 257. BRICS IMMUNOASSAY MARKET SIZE, BY APPLICATION AREAS, 2018-2032 (USD MILLION)
TABLE 258. BRICS IMMUNOASSAY MARKET SIZE, BY TOXICOLOGY, 2018-2032 (USD MILLION)
TABLE 259. BRICS IMMUNOASSAY MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
TABLE 260. BRICS IMMUNOASSAY MARKET SIZE, BY DEPLOYMENT TYPES, 2018-2032 (USD MILLION)
TABLE 261. G7 IMMUNOASSAY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 262. G7 IMMUNOASSAY MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 263. G7 IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 264. G7 IMMUNOASSAY MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 265. G7 IMMUNOASSAY MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 266. G7 IMMUNOASSAY MARKET SIZE, BY SAMPLE TYPES, 2018-2032 (USD MILLION)
TABLE 267. G7 IMMUNOASSAY MARKET SIZE, BY DETECTION MODES, 2018-2032 (USD MILLION)
TABLE 268. G7 IMMUNOASSAY MARKET SIZE, BY APPLICATION AREAS, 2018-2032 (USD MILLION)
TABLE 269. G7 IMMUNOASSAY MARKET SIZE, BY TOXICOLOGY, 2018-2032 (USD MILLION)
TABLE 270. G7 IMMUNOASSAY MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
TABLE 271. G7 IMMUNOASSAY MARKET SIZE, BY DEPLOYMENT TYPES, 2018-2032 (USD MILLION)
TABLE 272. NATO IMMUNOASSAY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 273. NATO IMMUNOASSAY MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 274. NATO IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 275. NATO IMMUNOASSAY MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 276. NATO IMMUNOASSAY MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 277. NATO IMMUNOASSAY MARKET SIZE, BY SAMPLE TYPES, 2018-2032 (USD MILLION)
TABLE 278. NATO IMMUNOASSAY MARKET SIZE, BY DETECTION MODES, 2018-2032 (USD MILLION)
TABLE 279. NATO IMMUNOASSAY MARKET SIZE, BY APPLICATION AREAS, 2018-2032 (USD MILLION)
TABLE 280. NATO IMMUNOASSAY MARKET SIZE, BY TOXICOLOGY, 2018-2032 (USD MILLION)
TABLE 281. NATO IMMUNOASSAY MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
TABLE 282. NATO IMMUNOASSAY MARKET SIZE, BY DEPLOYMENT TYPES, 2018-2032 (USD MILLION)
TABLE 283. UNITED STATES IMMUNOASSAY MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 284. UNITED STATES IMMUNOASSAY MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 285. UNITED STATES IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 286. UNITED STATES IMMUNOASSAY MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 287. UNITED STATES IMMUNOASSAY MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 288. UNITED STATES IMMUNOASSAY MARKET SIZE, BY SAMPLE TYPES, 2018-2032 (USD MILLION)
TABLE 289. UNITED STATES IMMUNOASSAY MARKET SIZE, BY DETECTION MODES, 2018-2032 (USD MILLION)
TABLE 290. UNITED STATES IMMUNOASSAY MARKET SIZE, BY APPLICATION AREAS, 2018-2032 (USD MILLION)
TABLE 291. UNITED STATES IMMUNOASSAY MARKET SIZE, BY TOXICOLOGY, 2018-2032 (USD MILLION)
TABLE 292. UNITED STATES IMMUNOASSAY MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
TABLE 293. UNITED STATES IMMUNOASSAY MARKET SIZE, BY DEPLOYMENT TYPES, 2018-2032 (USD MILLION)
TABLE 294. GERMANY IMMUNOASSAY MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 295. GERMANY IMMUNOASSAY MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 296. GERMANY IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 297. GERMANY IMMUNOASSAY MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 298. GERMANY IMMUNOASSAY MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 299. GERMANY IMMUNOASSAY MARKET SIZE, BY SAMPLE TYPES, 2018-2032 (USD MILLION)
TABLE 300. GERMANY IMMUNOASSAY MARKET SIZE, BY DETECTION MODES, 2018-2032 (USD MILLION)
TABLE 301. GERMANY IMMUNOASSAY MARKET SIZE, BY APPLICATION AREAS, 2018-2032 (USD MILLION)
TABLE 302. GERMANY IMMUNOASSAY MARKET SIZE, BY TOXICOLOGY, 2018-2032 (USD MILLION)
TABLE 303. GERMANY IMMUNOASSAY MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
TABLE 304. GERMANY IMMUNOASSAY MARKET SIZE, BY DEPLOYMENT TYPES, 2018-2032 (USD MILLION)
TABLE 305. CHINA IMMUNOASSAY MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 306. CHINA IMMUNOASSAY MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 307. CHINA IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 308. CHINA IMMUNOASSAY MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 309. CHINA IMMUNOASSAY MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 310. CHINA IMMUNOASSAY MARKET SIZE, BY SAMPLE TYPES, 2018-2032 (USD MILLION)
TABLE 311. CHINA IMMUNOASSAY MARKET SIZE, BY DETECTION MODES, 2018-2032 (USD MILLION)
TABLE 312. CHINA IMMUNOASSAY MARKET SIZE, BY APPLICATION AREAS, 2018-2032 (USD MILLION)
TABLE 313. CHINA IMMUNOASSAY MARKET SIZE, BY TOXICOLOGY, 2018-2032 (USD MILLION)
TABLE 314. CHINA IMMUNOASSAY MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
TABLE 315. CHINA IMMUNOASSAY MARKET SIZE, BY DEPLOYMENT TYPES, 2018-2032 (USD MILLION)
TABLE 316. UNITED KINGDOM IMMUNOASSAY MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 317. UNITED KINGDOM IMMUNOASSAY MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 318. UNITED KINGDOM IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 319. UNITED KINGDOM IMMUNOASSAY MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 320. UNITED KINGDOM IMMUNOASSAY MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 321. UNITED KINGDOM IMMUNOASSAY MARKET SIZE, BY SAMPLE TYPES, 2018-2032 (USD MILLION)
TABLE 322. UNITED KINGDOM IMMUNOASSAY MARKET SIZE, BY DETECTION MODES, 2018-2032 (USD MILLION)
TABLE 323. UNITED KINGDOM IMMUNOASSAY MARKET SIZE, BY APPLICATION AREAS, 2018-2032 (USD MILLION)
TABLE 324. UNITED KINGDOM IMMUNOASSAY MARKET SIZE, BY TOXICOLOGY, 2018-2032 (USD MILLION)
TABLE 325. UNITED KINGDOM IMMUNOASSAY MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
TABLE 326. UNITED KINGDOM IMMUNOASSAY MARKET SIZE, BY DEPLOYMENT TYPES, 2018-2032 (USD MILLION)
TABLE 327. INDIA IMMUNOASSAY MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 328. INDIA IMMUNOASSAY MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 329. INDIA IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 330. INDIA IMMUNOASSAY MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 331. INDIA IMMUNOASSAY MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 332. INDIA IMMUNOASSAY MARKET SIZE, BY SAMPLE TYPES, 2018-2032 (USD MILLION)
TABLE 333. INDIA IMMUNOASSAY MARKET SIZE, BY DETECTION MODES, 2018-2032 (USD MILLION)
TABLE 334. INDIA IMMUNOASSAY MARKET SIZE, BY APPLICATION AREAS, 2018-2032 (USD MILLION)
TABLE 335. INDIA IMMUNOASSAY MARKET SIZE, BY TOXICOLOGY, 2018-2032 (USD MILLION)
TABLE 336. INDIA IMMUNOASSAY MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
TABLE 337. INDIA IMMUNOASSAY MARKET SIZE, BY DEPLOYMENT TYPES, 2018-2032 (USD MILLION)
TABLE 338. JAPAN IMMUNOASSAY MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 339. JAPAN IMMUNOASSAY MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 340. JAPAN IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 341. JAPAN IMMUNOASSAY MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 342. JAPAN IMMUNOASSAY MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 343. JAPAN IMMUNOASSAY MARKET SIZE, BY SAMPLE TYPES, 2018-2032 (USD MILLION)
TABLE 344. JAPAN IMMUNOASSAY MARKET SIZE, BY DETECTION MODES, 2018-2032 (USD MILLION)
TABLE 345. JAPAN IMMUNOASSAY MARKET SIZE, BY APPLICATION AREAS, 2018-2032 (USD MILLION)
TABLE 346. JAPAN IMMUNOASSAY MARKET SIZE, BY TOXICOLOGY, 2018-2032 (USD MILLION)
TABLE 347. JAPAN IMMUNOASSAY MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
TABLE 348. JAPAN IMMUNOASSAY MARKET SIZE, BY DEPLOYMENT TYPES, 2018-2032 (USD MILLION)
TABLE 349. RUSSIA IMMUNOASSAY MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 350. RUSSIA IMMUNOASSAY MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 351. RUSSIA IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 352. RUSSIA IMMUNOASSAY MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 353. RUSSIA IMMUNOASSAY MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 354. RUSSIA IMMUNOASSAY MARKET SIZE, BY SAMPLE TYPES, 2018-2032 (USD MILLION)
TABLE 355. RUSSIA IMMUNOASSAY MARKET SIZE, BY DETECTION MODES, 2018-2032 (USD MILLION)
TABLE 356. RUSSIA IMMUNOASSAY MARKET SIZE, BY APPLICATION AREAS, 2018-2032 (USD MILLION)
TABLE 357. RUSSIA IMMUNOASSAY MARKET SIZE, BY TOXICOLOGY, 2018-2032 (USD MILLION)
TABLE 358. RUSSIA IMMUNOASSAY MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
TABLE 359. RUSSIA IMMUNOASSAY MARKET SIZE, BY DEPLOYMENT TYPES, 2018-2032 (USD MILLION)
TABLE 360. BRAZIL IMMUNOASSAY MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 361. BRAZIL IMMUNOASSAY MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 362. BRAZIL IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 363. BRAZIL IMMUNOASSAY MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 364. BRAZIL IMMUNOASSAY MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 365. BRAZIL IMMUNOASSAY MARKET SIZE, BY SAMPLE TYPES, 2018-2032 (USD MILLION)
TABLE 366. BRAZIL IMMUNOASSAY MARKET SIZE, BY DETECTION MODES, 2018-2032 (USD MILLION)
TABLE 367. BRAZIL IMMUNOASSAY MARKET SIZE, BY APPLICATION AREAS, 2018-2032 (USD MILLION)
TABLE 368. BRAZIL IMMUNOASSAY MARKET SIZE, BY TOXICOLOGY, 2018-2032 (USD MILLION)
TABLE 369. BRAZIL IMMUNOASSAY MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
TABLE 370. BRAZIL IMMUNOASSAY MARKET SIZE, BY DEPLOYMENT TYPES, 2018-2032 (USD MILLION)
TABLE 371. CANADA IMMUNOASSAY MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 372. CANADA IMMUNOASSAY MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 373. CANADA IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 374. CANADA IMMUNOASSAY MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 375. CANADA IMMUNOASSAY MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 376. CANADA IMMUNOASSAY MARKET SIZE, BY SAMPLE TYPES, 2018-2032 (USD MILLION)
TABLE 377. CANADA IMMUNOASSAY MARKET SIZE, BY DETECTION MODES, 2018-2032 (USD MILLION)
TABLE 378. CANADA IMMUNOASSAY MARKET SIZE, BY APPLICATION AREAS, 2018-2032 (USD MILLION)
TABLE 379. CANADA IMMUNOASSAY MARKET SIZE, BY TOXICOLOGY, 2018-2032 (USD MILLION)
TABLE 380. CANADA IMMUNOASSAY MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
TABLE 381. CANADA IMMUNOASSAY MARKET SIZE, BY DEPLOYMENT TYPES, 2018-2032 (USD MILLION)
TABLE 382. ITALY IMMUNOASSAY MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 383. ITALY IMMUNOASSAY MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 384. ITALY IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 385. ITALY IMMUNOASSAY MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 386. ITALY IMMUNOASSAY MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 387. ITALY IMMUNOASSAY MARKET SIZE, BY SAMPLE TYPES, 2018-2032 (USD MILLION)
TABLE 388. ITALY IMMUNOASSAY MARKET SIZE, BY DETECTION MODES, 2018-2032 (USD MILLION)
TABLE 389. ITALY IMMUNOASSAY MARKET SIZE, BY APPLICATION AREAS, 2018-2032 (USD MILLION)
TABLE 390. ITALY IMMUNOASSAY MARKET SIZE, BY TOXICOLOGY, 2018-2032 (USD MILLION)
TABLE 391. ITALY IMMUNOASSAY MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
TABLE 392. ITALY IMMUNOASSAY MARKET SIZE, BY DEPLOYMENT TYPES, 2018-2032 (USD MILLION)
TABLE 393. MEXICO IMMUNOASSAY MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 394. MEXICO IMMUNOASSAY MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 395. MEXICO IMMUNOASSAY MA

Companies Mentioned

The companies featured in this Immunoassay market report include:

Abbott Laboratories
Agilent Technologies Inc.
ANP Technologies, Inc.
Autobio Diagnostics Co., Ltd.
Becton, Dickinson and Company
Bio-Rad Laboratories, Inc.
Bio-Techne Corporation
bioMérieux S.A.
Biosurfit SA
Boditech Med Inc.
Danaher Corporation
Diasorin S.p.A.
Dynex Technologies, Inc.
Epitope Diagnostics Inc.
F. Hoffmann-La Roche Ltd.
Fapon Biotech Inc.
H.U. Group Holdings Inc.
J. Mitra & Co. Pvt. Ltd.
Kamiya Biomedical Company
Merck KGaA
MiCo BioMed, Inc.
NanoEntek
Nanōmix, Inc.
OPKO Health, Inc.
Promega Corporation
QIAGEN N.V.
Quanterix Corporation
Randox Laboratories Ltd.
Shenzhen Micropoint Biotechnologies Co., Ltd.
Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
Siemens Healthineers AG
Sysmex Corporation
Thermo Fisher Scientific Inc.
Tosoh Corporation
WAK-Chemie Medical GmbH
Zoetis Inc.
Zybio Inc.

Table Information

Report Attribute	Details
No. of Pages	182
Published	June 2026
Forecast Period	2026 - 2032
Estimated Market Value ( USD ) in 2026	$ 32.61 Billion
Forecasted Market Value ( USD ) by 2032	$ 49.98 Billion
Compound Annual Growth Rate	7.3%
Regions Covered	Global
No. of Companies Mentioned	38

License	Format	Properties	Price
1 - 5 USER LICENSE PDF, Excel and Online Access		This is a 1-5 user license, allowing up to five users have access to the product.	€3211EUR$3,545USD£2,770GBP €3568EUR$3,939USD£3,078GBP
ENTERPRISE LICENSE PDF, Excel and Online Access		This is an enterprise license, allowing all employees within your organization access to the product.	€4858EUR$5,363USD£4,191GBP €5398EUR$5,959USD£4,657GBP

Immunoassay Market by Type, Technology, Instruments, Sample Types, Detection Modes, Application Areas, End Users, Deployment Types - Global Forecast 2026-2032

Transformative Shifts in the Immunoassay Landscape

Cumulative Impact of Artificial Intelligence on Immunoassay

Key Regional Insights for Immunoassay

Key Group Insights for Immunoassay

Key Country Insights for Immunoassay

Actionable Recommendations for Immunoassay Industry Leaders

Research Methodology

Conclusion

Table of Contents

Companies Mentioned

Table Information

Transformative Shifts in the Immunoassay Landscape

Cumulative Impact of Artificial Intelligence on Immunoassay

Key Regional Insights for Immunoassay

Key Group Insights for Immunoassay

Key Country Insights for Immunoassay

Actionable Recommendations for Immunoassay Industry Leaders

Research Methodology

Conclusion

Table of Contents

Companies Mentioned

Table Information

Related Topics

Related Reports

Chemiluminescence Immunoassay Analyzers Market by Component, Type, Automation Level, Sample Type, Application Area, End User - Global Forecast 2026-2032

Automatic Chemiluminescence Immunoassay Analyzer Market - Global Forecast 2026-2032

Multiplex Detection Immunoassays - Global Strategic Business Report

Immunoassay Interference Blocker - Global Strategic Business Report

Immunoassay Interference Blocker Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)